Close Menu

NEW YORK (GenomeWeb) – Quidel today reported preliminary revenues for the fourth quarter of 2015 well below analyst forecasts.

Due to a weak influenza season, the firm now expects Q4 revenues between $52 million and $53 million, below analysts' consensus estimate of $64 million.

Investors reacted negatively to the news, sending Quidel's shares down around 7 percent to $17.67 in mid-morning trade on the Nasdaq. The shares had fallen to as low as $16.71 earlier in the session.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.